{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:06:02Z","timestamp":1778792762963,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13760-020-01464-6","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T17:03:59Z","timestamp":1597251839000},"page":"1283-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tiagabine-related status epilepticus: a case report and systematic literature review"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-3821","authenticated-orcid":false,"given":"Geoffroy","family":"Hariri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Legriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1059-1311(05)80160-8","volume":"3","author":"S Sveinbjornsdottir","year":"1994","unstructured":"Sveinbjornsdottir S, Sander JW, Patsalos PN et al (1994) Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 3:29\u201335","journal-title":"Seizure"},{"key":"1464_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4088\/JCP.v64n1016","volume":"64","author":"M Rosenthal","year":"2003","unstructured":"Rosenthal M (2003) Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry 64:1245\u20131249","journal-title":"J Clin Psychiatry"},{"key":"1464_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jocn.2004.03.027","volume":"12","author":"A Vinton","year":"2005","unstructured":"Vinton A, Kornberg AJ, Cowley M et al (2005) Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy. J Clin Neurosci 12:128\u2013133. https:\/\/doi.org\/10.1016\/j.jocn.2004.03.027","journal-title":"J Clin Neurosci"},{"key":"1464_CR4","first-page":"152","volume":"12","author":"NI Haddad","year":"2007","unstructured":"Haddad NI, Umashankar G, Harik SI (2007) Tiagabine-induced non-convulsive status epilepticus in a patient without history of epilepsy. Neurosciences (Riyadh) 12:152\u2013154","journal-title":"Neurosciences (Riyadh)"},{"key":"1464_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MJT.0b013e31815b04d4","volume":"15","author":"JB Leikin","year":"2008","unstructured":"Leikin JB, Benigno J, Dubow JS, Fisher M (2008) Status epilepticus due to tiagabine ingestion. Am J Ther 15:290. https:\/\/doi.org\/10.1097\/MJT.0b013e31815b04d4","journal-title":"Am J Ther"},{"key":"1464_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/01.wnl.0000252370.51970.07","volume":"68","author":"C Vollmar","year":"2007","unstructured":"Vollmar C, Noachtar S (2007) Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient. Neurology 68:310. https:\/\/doi.org\/10.1212\/01.wnl.0000252370.51970.07","journal-title":"Neurology"},{"key":"1464_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s004150170244","volume":"248","author":"S Skodda","year":"2001","unstructured":"Skodda S, Kramer I, Spittler JF, Gehlen W (2001) Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol 248:109\u2013112. https:\/\/doi.org\/10.1007\/s004150170244","journal-title":"J Neurol"},{"key":"1464_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1059-1311(02)00293-5","volume":"12","author":"D Imperiale","year":"2003","unstructured":"Imperiale D, Pignatta P, Cerrato P et al (2003) Nonconvulsive status epilepticus due to a de novo contralateral focus during tiagabine adjunctive therapy. Seizure 12:319\u2013322","journal-title":"Seizure"},{"key":"1464_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1684\/j.1950-6945.2001.tb00386.x","volume":"3","author":"S Fitzek","year":"2001","unstructured":"Fitzek S, Hegemann S, Sauner D et al (2001) Drug-induced nonconvulsive status epilepticus with low dose of tiagabine. Epileptic Disord 3:147\u2013150","journal-title":"Epileptic Disord"},{"key":"1464_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/seiz.2001.0560","volume":"11","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Vaughn BV (2002) Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure. Seizure 11:57\u201359. https:\/\/doi.org\/10.1053\/seiz.2001.0560","journal-title":"Seizure"},{"key":"1464_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/seiz.1998.0223","volume":"8","author":"E Trinka","year":"1999","unstructured":"Trinka E, Moroder T, Nagler M et al (1999) Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure 8:41\u201344. https:\/\/doi.org\/10.1053\/seiz.1998.0223","journal-title":"Seizure"},{"key":"1464_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/seiz.1999.0303","volume":"8","author":"S Knake","year":"1999","unstructured":"Knake S, Hamer HM, Schomburg U et al (1999) Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 8:314\u2013317. https:\/\/doi.org\/10.1053\/seiz.1999.0303","journal-title":"Seizure"},{"key":"1464_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1528-1157.1998.tb01438.x","volume":"39","author":"KM Eckardt","year":"1998","unstructured":"Eckardt KM, Steinhoff BJ (1998) Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 39:671\u2013674","journal-title":"Epilepsia"},{"key":"1464_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1528-1157.2002.51601.x","volume":"43","author":"D Ostrovskiy","year":"2002","unstructured":"Ostrovskiy D, Spanaki MV, Morris GL (2002) Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 43:773\u2013774. https:\/\/doi.org\/10.1046\/j.1528-1157.2002.51601.x","journal-title":"Epilepsia"},{"key":"1464_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1059-1311(96)80111-7","volume":"5","author":"G Schapel","year":"1996","unstructured":"Schapel G, Chadwick D (1996) Tiagabine and non-convulsive status epilepticus. Seizure 5:153\u2013156. https:\/\/doi.org\/10.1016\/S1059-1311(96)80111-7","journal-title":"Seizure"},{"key":"1464_CR16","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1212\/01.wnl.0000223336.07466.f3","volume":"67","author":"N Jette","year":"2006","unstructured":"Jette N, Cappell J, VanPassel L, Akman CI (2006) Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy. Neurology 67:1514\u20131515. https:\/\/doi.org\/10.1212\/01.wnl.0000223336.07466.f3","journal-title":"Neurology"},{"key":"1464_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jemermed.2004.06.003","volume":"27","author":"FL Cantrell","year":"2004","unstructured":"Cantrell FL, Ritter M, Himes E (2004) Intentional overdose with tiagabine: an unusual clinical presentation. J Emerg Med 27:271\u2013272. https:\/\/doi.org\/10.1016\/j.jemermed.2004.06.003","journal-title":"J Emerg Med"},{"key":"1464_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1742-6723.2007.00973.x","volume":"19","author":"RA Forbes","year":"2007","unstructured":"Forbes RA, Kalra H, Hackett LP, Daly FF (2007) Deliberate self-poisoning with tiagabine: an unusual toxidrome. Emerg Med Australas 19:556\u2013558. https:\/\/doi.org\/10.1111\/j.1742-6723.2007.00973.x","journal-title":"Emerg Med Australas"},{"key":"1464_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/seiz.2001.0594","volume":"11","author":"C Kellinghaus","year":"2002","unstructured":"Kellinghaus C, Dziewas RWW-U, L\u00fcdemann PG (2002) Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 11:243\u2013249. https:\/\/doi.org\/10.1053\/seiz.2001.0594","journal-title":"Seizure"},{"key":"1464_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1528-1157.1999.tb00835.x","volume":"40","author":"AB Ettinger","year":"1999","unstructured":"Ettinger AB, Bernal OG, Andriola MR et al (1999) Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 40:1159\u20131162","journal-title":"Epilepsia"},{"key":"1464_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1525-5050(03)00107-0","volume":"4","author":"V de Borchgrave","year":"2003","unstructured":"de Borchgrave V, Lienard F, Willemart Th, van Rijckevorsel K (2003) Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy. Epilepsy Behav 4:326\u2013337. https:\/\/doi.org\/10.1016\/S1525-5050(03)00107-0","journal-title":"Epilepsy Behav"},{"key":"1464_CR22","first-page":"19","volume":"102","author":"R Brouns","year":"2002","unstructured":"Brouns R, Van Paesschen W (2002) Recurrent complex partial status epilepticus associated with tiagabine rechallenge. Acta Neurol Belg 102:19\u201320","journal-title":"Acta Neurol Belg"},{"key":"1464_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1059-1311(03)00102-X","volume":"12","author":"A Skardoutsou","year":"2003","unstructured":"Skardoutsou A, Voudris KA, Vagiakou EA (2003) Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure 12:599\u2013601. https:\/\/doi.org\/10.1016\/S1059-1311(03)00102-X","journal-title":"Seizure"},{"key":"1464_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0387-7604(03)00028-7","volume":"25","author":"S Mangano","year":"2003","unstructured":"Mangano S, Cusumano L, Fontana A (2003) Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Develop 25:518\u2013521. https:\/\/doi.org\/10.1016\/S0387-7604(03)00028-7","journal-title":"Brain Develop"},{"key":"1464_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1053\/ejpn.2000.0293","volume":"4","author":"T Balslev","year":"2000","unstructured":"Balslev T, Uldall P, Buchholt J (2000) Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients. Euro J Paediatr Neurol 4:169\u2013170. https:\/\/doi.org\/10.1053\/ejpn.2000.0293","journal-title":"Euro J Paediatr Neurol"},{"key":"1464_CR26","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/j.1528-1157.2000.tb00126.x","volume":"41","author":"P Piccinelli","year":"2000","unstructured":"Piccinelli P, Borgatti R, Perucca E et al (2000) Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Epilepsia 41:1485\u20131488. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00126.x","journal-title":"Epilepsia"},{"key":"1464_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/15563650500357586","volume":"43","author":"JA Fulton","year":"2005","unstructured":"Fulton JA, Hoffman RS, Nelson LS (2005) Tiagabine overdose: a case of status epilepticus in a non-epileptic patient. Clin Toxicol 43:869\u2013871. https:\/\/doi.org\/10.1080\/15563650500357586","journal-title":"Clin Toxicol"},{"key":"1464_CR28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/j.1528-1167.2005.00263.x","volume":"46","author":"MJ Koepp","year":"2005","unstructured":"Koepp MJ, Edwards M, Collins J et al (2005) Status epilepticus and tiagabine therapy revisited. Epilepsia 46:1625\u20131632. https:\/\/doi.org\/10.1111\/j.1528-1167.2005.00263.x","journal-title":"Epilepsia"},{"key":"1464_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.yebeh.2013.02.016","volume":"27","author":"NJ Azar","year":"2013","unstructured":"Azar NJ, Bangalore-Vittal N, Arain A, Abou-Khalil BW (2013) Tiagabine-induced stupor in patients with psychogenic nonepileptic seizures: nonconvulsive status epilepticus or encephalopathy? Epilepsy Behav 27:330\u2013332. https:\/\/doi.org\/10.1016\/j.yebeh.2013.02.016","journal-title":"Epilepsy Behav"},{"key":"1464_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.yebeh.2013.12.027","volume":"31","author":"K Hamandi","year":"2014","unstructured":"Hamandi K, Myers J, Muthukumaraswamy S (2014) Tiagabine-induced stupor\u2014more evidence for an encephalopathy. Epilepsy Behav 31:196\u2013197. https:\/\/doi.org\/10.1016\/j.yebeh.2013.12.027","journal-title":"Epilepsy Behav"},{"key":"1464_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(97)05035-6","volume":"351","author":"JP Leach","year":"1998","unstructured":"Leach JP, Brodie MJ (1998) Tiagabine. Lancet 351:203\u2013207. https:\/\/doi.org\/10.1016\/S0140-6736(97)05035-6","journal-title":"Lancet"},{"key":"1464_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s0006-8993(99)01654-6","volume":"838","author":"PK Chan","year":"1999","unstructured":"Chan PK, Yung WH (1999) Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake. Brain Res 838:18\u201326. https:\/\/doi.org\/10.1016\/s0006-8993(99)01654-6","journal-title":"Brain Res"},{"key":"1464_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0920-1211(99)00029-7","volume":"37","author":"MF Jackson","year":"1999","unstructured":"Jackson MF, Esplin B, Capek R (1999) Activity-dependent enhancement of hyperpolarizing and depolarizing gamma-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine. Epilepsy Res 37:25\u201336","journal-title":"Epilepsy Res"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01464-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T18:38:43Z","timestamp":1723401523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01464-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01464-6","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that there are no competing interests. Geoffroy Hariri: reports no financial relationships relevant to the study. Alexis Ferre: reports no financial relationships relevant to the study. Stephane Legriel: reports no financial relationships relevant to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For the case we report, informed consent was given by the family of the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}